Request a Program

Leave this field empty

IRON DEFICIENCY ANEMIA 2018

Preferred Speaker(pick two)

Preferred Date(pick two)

Preferred Format(pick one)





PERSONAL INFORMATION

Name

Address

City

State

Zip

Email

Phone

Fax

Request a Program

Thank you!

A representative will contact you shortly.

LIVE MEETINGS
  • Please select a series
  • GHAPP

CME Information

Series Start Date: November 21, 2019

Series End Date: December 5, 2019


Target Audience

This activity has been designed to meet the educational needs of nurse practitioners and physician assistants involved in the management of patients with GI disorders and chronic liver disease.

Educational Objectives

After completing this activity, participants should be better able to:

Describe current screening, diagnosis and management options for patients with CLD and GI disorders.

Optimize treatment results for patients with CLD and GI disorders

Compare and contrast currently available treatment modalities for CLD and GI disorders.


ANCC Accreditation

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

A maximum of 3.0 contact hours may be earned for successful completion of this activity.

AANP Accreditation

This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Annenberg Center for Health Sciences, Gi Health Foundation and Chronic Liver Disease Foundation. Annenberg Center for Health Sciences is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 040207

This program is accredited for 3.0 contact hour(s).

AAPA Accreditation

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 12.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

This activity was planned in accordance with AAPA CME Standards for Live Programs and for Commercial Support of Live Programs.

Disclosure of conflicts of interest

All faculty and staff involved in the planning or presentation of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Staff at the Annenberg Center for Health Sciences at Eisenhower, Gi Health Foundation and Chronic Liver Disease Foundation have no relationships to disclose.

Learner Assurance Statement:

The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members' significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

This activity is supported by educational grants from: AbbVie, AMAG Pharmaceuticals, American Regent, Gilead, Intercept Pharmaceuticals, Mallinckrodt Pharmaceuticals, Pfizer Inc., Prometheus Laboratories Inc., Salix Pharmaceuticals and Takeda

Accredited by:


Jointly Provided by:

Americans with Disabilities Act

The event staff will be glad to assist you with any special needs (i.e., physical, dietary). Please contact us prior to the event at 1-877-782-4532.

Meetings

  • Speakers
  • Date
  • Location

Please check back later!

© Copyright 2013-2019 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.